Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Sudarshan Sukhani of s2analytics.com, one can buy Torrent Pharma, Divis Labs, LIC Housing Finance and Adani Ports.
Sandeep Wagle of powermywealth.com recommends buying Cadila Healthcare, ACC, Torrent Pharma and BPCL.
In an interview to CNBC-TV18, Pankaj Sharma of Equirus Securities shares his views on FMCG space and expects better volumes with Britannia Industries as a good choice.
Sandeep Wagle of powermywealth.com is of the view that one can sell Rural Electrification Corporation and Idea Cellular and buy Torrent Pharma.
In an interview to CNBC-TV18, Daljeet Singh Kohli of India Nivesh Securites shared his readings and outlook on specific stocks and sector.
Manoj Murlidharan of Religare Securities feels that Bharat Petroleum Corporation may test Rs 1030 and Torrent Pharma may move to Rs 1480.
Ashwani Gujral of ashwanigujral.com is of the view that Hindustan Unilever may test Rs 1050 while Tata Motors may hit Rs 550-600.
Ashwani Gujral of ashwanigujral.com recommends buying Biocon and Dabur India and advises selling Tata Steel, Ajanta Pharma and Dish TV.
Ashwani Gujral of ashwanigujral.com recommends buying UPL and Tata Chemicals and advises selling Torrent Pharma.
According to Ashwani Gujral of ashwanigujral.com, Lupin may test Rs 1800-1900 while GATI can touch Rs 155.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Union Bank, Karnataka Bank and Havells India.
Gaurav Bissa of LKP Securities recommends buying Marico with a target of Rs 270 and advises selling BHEL with a target of Rs 120.
Sudarshan Sukhani of s2analytics.com recommends buying Marico, UPL and Torrent Pharma.
Ashwani Gujral of ashwanigujral.com recommends buying Jain Irrigation Systems, midcap pharma, Reliance Capital and Reliance Infrastructure.
Prakash Gaba of prakashgaba.com is of the veiw that L&T Finance Holdings may test Rs 76 while IRB Infra may hit Rs 210.
Ashwani Gujral of ashwanigujral.com recommends buying Torrent Pharma and Ajanta Pharma and advises selling Mindtree.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy India Cements and Havells India.
Ashwani Gujral of ashwanigujral.com recommends buying TCS, JSW Steel, Torrent Pharma and Ajanta Pharma.
Sandeep Wagle of Powermywealth.com recommends buying Bata India, Torrent Pharma and Jet Airways.
Here are a few top buzzing stocks picked up by CNBC-TV18's analysts in trade today - Lupin, Torrent Pharma, LT Foods, JSW Energy, Crompton Greaves, Page Ind and Bhushan Steel.
Ashwani Gujral of ashwanigujral.com recommends buying Bank of Baroda and Tata Steel and advises selling Hindustan Unilever.
Sudarshan Sukhani of s2analytics.com recommends buying State bank of India and Axis Bank and feels that Torrent Pharma may go down.
Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.
Gaurang Shah of Geojit BNP Paribas feels that Torrent Pharmaceuticals may move to Rs 1460.
Manoj Murlidharan of Religare Securities recommends buying Cipla, Torrent Pharma, HCL Tech and TVS Motor.